GABRG2 rs761100: Understanding Genetic Associations with Epilepsy
The rs761100 variant is located within the GABRG2 gene, which provides instructions for creating a critical component of the brain's inhibitory signaling system. Variations in this gene are studied for their potential associations with epilepsy syndromes, including generalized epilepsy with febrile seizures plus (GEFS+).
What each genotype means
Typical GABRG2 profile
This genotype represents the most common version of the GABRG2 gene found in the general population. While GABRG2 variants are linked to epilepsy syndromes like GEFS+, this specific genotype is not associated with an increased risk of these conditions. Please note that epilepsy is a complex condition influenced by many genetic and environmental factors.
This is the most common genotype observed across all major global populations.
Common variant carrier
Carrying one copy of this variant is common and is generally considered part of normal human genetic diversity. While the GABRG2 gene is involved in brain signaling and is associated with epilepsy in the context of rare, pathogenic mutations, this specific common variant does not carry a known clinical diagnosis or high risk. If you have concerns about seizure history, please consult with a neurologist.
This genotype is found at varying frequencies globally, appearing in a significant portion of the population.
Common variant carrier
This genotype is a common variation in the GABRG2 gene and is not typically associated with clinical disease. Although rare, specific mutations in GABRG2 can contribute to epilepsy syndromes, this common variant is not considered a primary cause of such conditions. You should discuss any personal or family history of seizures with a healthcare professional.
This genotype is present in a subset of the population, with frequencies varying by ancestral background.
What is the rs761100 Variant?
The rs761100 variant is a specific single nucleotide polymorphism (SNP) situated within the GABRG2 gene. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. This particular variant is cataloged in public databases as a common genetic marker. While many SNPs have no observable effect on health, researchers monitor specific variants in genes like GABRG2 because they may influence how the body produces proteins or regulates cellular processes. Because rs761100 is common, it is found frequently in the general population, and its presence alone does not indicate a medical condition. Instead, it serves as a point of interest for scientists studying the genetic architecture of neurological health and the complex interplay between inherited DNA and seizure susceptibility.
The Role of the GABRG2 Gene
The GABRG2 gene encodes the gamma-2 subunit of the GABA-A receptor. These receptors are essential for the function of the central nervous system, acting as the primary inhibitory neurotransmitter system in the brain. By allowing chloride ions to enter neurons, GABA-A receptors help dampen electrical activity, effectively acting as a 'brake' on the brain's signaling pathways. When these receptors function correctly, they maintain a balance between excitation and inhibition. If the structure or function of the gamma-2 subunit is altered, this balance can be disrupted, potentially leading to increased neuronal excitability. Research into GABRG2 is significant because mutations in this gene have been linked to a spectrum of conditions, ranging from simple febrile seizures to more complex epilepsy syndromes, highlighting the gene's importance in maintaining neurological stability.
Research and Clinical Associations
Scientific literature has established that GABRG2 is a key gene in the study of genetic epilepsy with febrile seizures plus (GEFS+). GEFS+ is a familial condition characterized by a range of seizure types, often beginning in childhood with febrile seizures and sometimes progressing to other forms of epilepsy. While rare, pathogenic mutations in GABRG2 are well-documented as causes for these conditions. However, it is important to distinguish between rare, highly penetrant mutations and common variants like rs761100. Current research often investigates whether common variants contribute to the overall polygenic risk—the cumulative effect of many small genetic changes—that influences an individual's susceptibility to seizures. The evidence for rs761100 specifically is considered moderate in the context of broad health predispositions, and it is not typically classified as a primary diagnostic marker for epilepsy.
Population Frequency and Interpretation
The rs761100 variant is classified as common, meaning it appears frequently across diverse human populations. In genetic studies, common variants are often analyzed to understand how they might modify the risk of complex diseases. Because this variant is widespread, the vast majority of people who carry it do not experience epilepsy or febrile seizures. Genetic predisposition is rarely determined by a single SNP; rather, it is the result of a complex interaction between an individual's entire genetic background and environmental factors. If you have received information about this variant through genetic testing, it is essential to view it as one small piece of a much larger biological puzzle. It does not provide a definitive prediction of health outcomes, and it should not be used to make medical decisions without professional guidance.
What You Can Do With This Information
Understanding your genetic profile can be an educational experience, but it is not a substitute for clinical evaluation. If you or a family member have concerns about seizures, epilepsy, or neurological health, the most important step is to consult with a neurologist or a genetic counselor. These professionals can interpret genetic findings within the context of your personal and family medical history. You should never use information about a common variant like rs761100 to diagnose yourself or alter any prescribed medications. If you are currently taking anti-epileptic drugs, always discuss any questions regarding your treatment or dosing with your clinician or pharmacist. They are the only ones qualified to provide medical advice based on your specific clinical needs and the latest evidence-based practices.
How common is this variant?
The rs761100 variant is a common polymorphism found across global populations, with its specific genotype frequencies varying by ancestry.
Frequently asked questions
Is rs761100 a cause of epilepsy?
No, rs761100 is a common genetic variant and is not considered a direct cause of epilepsy. While the GABRG2 gene is associated with epilepsy, rare pathogenic mutations are typically the cause of inherited seizure disorders, not common SNPs.
Should I be worried if I have this variant?
No, there is no reason for concern. Because this variant is common, it is present in many healthy individuals who have no history of seizures or neurological conditions.
Can I use this information to predict my risk of seizures?
No, this variant cannot be used to predict your risk of seizures. Epilepsy is a complex condition influenced by many genetic and environmental factors, and a single common SNP does not provide meaningful predictive power.
Where can I learn more about GABRG2?
You can find reliable information about the GABRG2 gene and its role in health through resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI) Gene database.
Sources & further reading
Educational information only, last refreshed 9/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs761100?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.